Glycobiology, 2001, Vol. 11, No. 6 91R-98R
© 2001 Oxford University Press
MINI REVIEW |
Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans
Division of Molecular Biology and Biochemistry, School of Biological Sciences, University of Missouri-Kansas City, Kansas City, MO 64110, USA
Abstract
Heparanases are endoglycosidases that cleave the heparan sulfate glycosaminoglycans from proteoglycan core proteins and degrade them to small oligosaccharides. Inside cells, these enzymes are important for the normal catabolism of heparan sulfate proteoglycans (HSPGs), generating glycosaminoglycan fragments that are then transported to lysosomes and completely degraded. When secreted, heparanases are thought to degrade basement membrane HSPGs at sites of injury or inflammation, allowing extravasion of immune cells into nonvascular spaces and releasing factors that regulate cell proliferation and angiogenesis. Heparanases have been described in a wide variety of tissues and cells, but because of difficulties in developing simple assays to follow activity, very little has been known about enzyme diversity until recently. Within the last 10 years, heparanases have been purified from platelets, placenta, and Chinese hamster ovary cells. Characterization of the enzymes suggests there may be a family of heparanase proteins with different substrate specificities and potential functions.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. N. Harris and P. H. Weigel The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E Glycobiology, August 1, 2008; 18(8): 638 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. N. Harris, J. A. Weigel, and P. H. Weigel The Human Hyaluronan Receptor for Endocytosis (HARE/Stabilin-2) Is a Systemic Clearance Receptor for Heparin J. Biol. Chem., June 20, 2008; 283(25): 17341 - 17350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S D'Souza, A. T Fazleabas, P. Banerjee, J. R. A Sherwin, A. M Sharkey, M. C Farach-Carson, and D. D Carson Decidual Heparanase Activity Is Increased During Pregnancy in the Baboon (Papio anubis) and in In Vitro Decidualization of Human Stromal Cells Biol Reprod, February 1, 2008; 78(2): 316 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. N. Patel, S. M. Knox, K. M. Likar, C. A. Lathrop, R. Hossain, S. Eftekhari, J. M. Whitelock, M. Elkin, I. Vlodavsky, and M. P. Hoffman Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis Development, December 1, 2007; 134(23): 4177 - 4186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S D'Souza, T. Daikoku, M. C Farach-Carson, and D. D Carson Heparanase Expression and Function During Early Pregnancy in Mice Biol Reprod, September 1, 2007; 77(3): 433 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Schenauer, Y. Yu, M. D. Sweeney, and J. A. Leary CCR2 Chemokines Bind Selectively to Acetylated Heparan Sulfate Octasaccharides J. Biol. Chem., August 31, 2007; 282(35): 25182 - 25188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Lewandrowski, J. Moebius, U. Walter, and A. Sickmann Elucidation of N-Glycosylation Sites on Human Platelet Proteins: A Glycoproteomic Approach Mol. Cell. Proteomics, February 1, 2006; 5(2): 226 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Taylor and R. L. Gallo Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation FASEB J, January 1, 2006; 20(1): 9 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. L. Wu and M. Lech Characterizing the Non-reducing End Structure of Heparan Sulfate J. Biol. Chem., October 7, 2005; 280(40): 33749 - 33755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Vreys, N. Delande, Z. Zhang, C. Coomans, A. Roebroek, J. Durr, and G. David Cellular Uptake of Mammalian Heparanase Precursor Involves Low Density Lipoprotein Receptor-related Proteins, Mannose 6-Phosphate Receptors, and Heparan Sulfate Proteoglycans J. Biol. Chem., September 30, 2005; 280(39): 33141 - 33148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fuller, P. J. Meikle, and J. J. Hopwood Glycosaminoglycan degradation fragments in mucopolysaccharidosis I Glycobiology, May 1, 2004; 14(5): 443 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sasaki, N. Higashi, T. Taka, M. Nakajima, and T. Irimura Cell Surface Localization of Heparanase on Macrophages Regulates Degradation of Extracellular Matrix Heparan Sulfate J. Immunol., March 15, 2004; 172(6): 3830 - 3835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Simizu, K. Ishida, M. K. Wierzba, and H. Osada Secretion of Heparanase Protein Is Regulated by Glycosylation in Human Tumor Cell Lines J. Biol. Chem., January 23, 2004; 279(4): 2697 - 2703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B. Johnson, G. J. Brunn, and J. L. Platt Cutting Edge: An Endogenous Pathway to Systemic Inflammatory Response Syndrome (SIRS)-Like Reactions through Toll-Like Receptor 4 J. Immunol., January 1, 2004; 172(1): 20 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kuberan, D. L. Beeler, M. Lech, Z. L. Wu, and R. D. Rosenberg Chemoenzymatic Synthesis of Classical and Non-classical Anticoagulant Heparan Sulfate Polysaccharides J. Biol. Chem., December 26, 2003; 278(52): 52613 - 52621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. GOTTE Syndecans in inflammation FASEB J, April 1, 2003; 17(6): 575 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Goldshmidt, E. Zcharia, R. Abramovitch, S. Metzger, H. Aingorn, Y. Friedmann, V. Schirrmacher, E. Mitrani, and I. Vlodavsky Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis PNAS, July 23, 2002; 99(15): 10031 - 10036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Vincent, M. Hermansson, M. Bolton, R. Wait, and J. Saklatvala Basic FGF mediates an immediate response of articular cartilage to mechanical injury PNAS, June 11, 2002; 99(12): 8259 - 8264. [Abstract] [Full Text] [PDF]
|
|